三维斑点追踪技术评价糖尿病微血管病变患者的左心室功能
Evaluation of Left Ventricular Function in Diabetes Patients with Microvascular Disease by Three-Dimensional Speckle Tracking Imaging
摘要: 目的:应用三维斑点追踪成像(3D-STI)评价2型糖尿病(T2DM)患者左心室三维应变,并讨论其与糖化血红蛋白(HbA1c)的关系。方法:收集临床诊断为T2DM的患者51例,分为无微血管病变组(DM1组) 21例、合并微血管病变组(DM2组) 30例,同时选取25例健康志愿者作为正常对照组,应用二维超声心动图测量左心房前后径(LAD)、左心室舒张末期内径(LVDd)、左心室收缩末期内径(LVDs)、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、二尖瓣口舒张早期峰值流速(E)、二尖瓣口舒张晚期峰值速度(A)、二尖瓣环舒张早期峰值速度(e’)、左室射血分数(2D-LVEF)。应用3D-STI采集心尖全容积图像获得左心室整体长轴应变(GLS)、左心室整体轴向应变(GCS)、左心室整体径向应变(GRS)、左心室射血分数(3D-LVEF)及左心室质量(LVM)等参数,比较各指标组间差异,分析其与HbA1c的相关性。结果:IVST、E/A、e’、E/e’这4个指标在3组间差异有统计学意义(P < 0.001),LVPWT在3组间差异有统计学意义(P < 0.05);在组间两两比较中,IVST、LVPWT、E/A、e’、E/e’在DM2组与对照组、DM2组与DM1组间差异有统计学意义;与对照组相比,DM2组的IVST、LVPWT、E/e’增大,e’、E/A减小;与DM1组相比,DM2组的IVST、LVPWT、E/e’增大,e’、E/A减小。GCS、GLS、GRS、LVM、3D-LVEF这5个参数在3组间差异有统计学意义(P < 0.001),组间两两比较中,GCS、GLS、GRS、LVM、3D-LVEF在DM1组与对照组、DM2组与对照组、DM2组与DM1组的组间差异有统计学意义:与对照组相比,DM1组、DM2组的GCS、GLS、LVM增大,GRS、3D-LVEF减小;与DM1组相比,DM2组的GCS、GLS、LVM增大,GRS、3D-LVEF减小。相关性分析显示,HbA1c与GCS、GLS、GRS、LVM、3D-LVEF均成负相关(r = −0.637、−0.562、−0.515、−0.606、−0.598,P < 0.001)。结论:T2DM患者左心室收缩与舒张功能均受损,其中,3D-STI指标组间差异更为显著,3D-STI可精准评估二型糖尿病患者左心功能状态,为临床及时防治T2DM患者心功能损害的发展提供有效依据。
Abstract: Objective: To evaluate the three-dimensional strain of the left ventricle in patients with type 2 dia-betes mellitus (T2DM) by three-dimensional speckle tracking imaging (3D-STI), and discuss the re-lationship between the three-dimensional strain and HbA1c. Method: A total of 51 patients who were clinically confirmed T2DM were collected and divided into a group of 21 patients without mi-crovascular disease (DM1 group) and a group of 30 patients with microvascular disease (DM2 group), and 25 healthy volunteers were selected as the control group at the same time. Two- di-mensional echocardiography was applied to measure the left atrial anteroposterior diameter (LAD), left ventricular end diastolic diameter (LVDd), left ventricular end systolic diameter (LVDs), and in-terventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), early peak diastolic flow rate (E), late peak diastolic flow rate (A), early peak diastolic velocity (e’) and left ven-tricular ejection fraction (2D-LVEF). 3D-STI was applied to collect apical full volume images, param-eters including left ventricular global long axis strain (GLS), left ventricular global axial strain (GCS), left ventricular global radial strain (GRS), left ventricular ejection fraction (3D-LVEF), and left ven-tricular mass (LVM) in order to access the differences between 3 groups of these parameters and explore their correlation with HbA1c. Result: The four parameters of IVST, E/A, e’, and E/e’ showed statistically significant differences among the three groups (P < 0.001), while LVPWT showed statis-tically significant differences among the three groups (P < 0.05). In pairwise comparisons between groups, there were statistically significant differences in IVST, LVPWT, E/A, e’, E/e’ between the DM2 group and the control group, as well as between the DM2 group and the DM1 group; Compared with the control group, the IVST, LVPWT, and E/e’ of the DM2 group increased, while e’ and E/A de-creased; Compared with the DM1 group, the IVST, LVPWT, and E/e’ of the DM2 group increased, while e’ and E/A decreased. The five parameters GCS, GLS, GRS, LVM and 3D-LVEF showed statisti-cally significant differences among the three groups (P < 0.001). In pairwise comparisons between the groups, GCS, GLS, GRS, LVM and 3D-LVEF showed statistically significant differences between the DM1 group and the control group, DM2 group and the control group, and DM2 group and DM1 group: compared with the control group, the GCS, GLS and LVM of the DM1 and DM2 groups in-creased, while the GRS and 3D-LVEF of the DM1 and DM2 groups decreased; Compared with the DM1 group, the GCS, GLS and LVM of the DM2 group increased, while the GRS and 3D-LVEF of the DM2 group decreased. Correlation analysis showed that HbA1c was negatively correlated with GCS, GLS, GRS, LVM, and 3D-LVEF (r = −0.637, −0.562, −0.515, −0.606, −0.598, P < 0.001). Conclusion: The left ventricular systolic and diastolic functions of T2DM patients were impaired, among which, the differences between 3D-STI parameters were more significant. 3D-STI can accurately assess the left ventricular function status of type II diabetes patients, so as to prevent and treat the heart function damage of T2DM patients timely.
文章引用:周青, 何香芹, 马建敏, 孙瑞聪, 姜志荣. 三维斑点追踪技术评价糖尿病微血管病变患者的左心室功能[J]. 临床医学进展, 2023, 13(12): 18908-18916. https://doi.org/10.12677/ACM.2023.13122660

参考文献

[1] Demir, S., Nawroth, P.P., Herzig, S. and Üstünel, B.E. (2021) Emerging Targets in Type 2 Diabetes and Diabetic Com-plications. Advanced Science, 8, e2100275. [Google Scholar] [CrossRef] [PubMed]
[2] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[3] Asbun, J. and Villarreal, F.J. (2006) The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy. Journal of the American College of Cardiology, 47, 693-700. [Google Scholar] [CrossRef] [PubMed]
[4] Hamby, R.I., Zoneraich, S. and Sherman, L. (1974) Diabetic Cardiomyopathy. JAMA, 229, 1749-1754. [Google Scholar] [CrossRef] [PubMed]
[5] Yang, W., Lu, J., Weng, J., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1101. [Google Scholar] [CrossRef
[6] Ritchie, R.H. and Abel, E.D. (2020) Basic Mechanisms of Diabetic Heart Disease. Circulation Research, 126, 1501-1525. [Google Scholar] [CrossRef
[7] Jia, G., Whaley-Connell, A. and Sowers, J.R. (2018) Diabetic Cardiomyopathy: A Hyperglycaemia- and Insulin- Resistance-Induced Heart Disease. Diabetologia, 61, 21-28. [Google Scholar] [CrossRef] [PubMed]
[8] 邹燕珂, 黄晶, 熊波, 等. 三维斑点追踪成像评价糖尿病患者心脏损害的Meta分析[J]. 中国介入影像与治疗学, 2017, 14(2): 86-91.
[9] 梁丽媚, 刘红利, 张会欣, 等. 三维斑点追踪成像评价代谢因素对2型糖尿病患者左室结构和功能的影响[J]. 临床心血管病杂志, 2021, 37(12): 1111-1116.
[10] Chen, X., Guo, H., Yang, Q., et al. (2020) Quantitative Evaluation of Subclinical Left Ventricular Dysfunction in Patients with Type 2 Diabetes Mellitus by Three-Dimensional Echocardiography. The International Journal of Cardiovascular Imaging, 36, 1311-1319. [Google Scholar] [CrossRef] [PubMed]
[11] 彭松夏, 徐怡, 孙霞, 等. 三维斑点追踪技术评价糖尿病足患者左室功能的价值[J]. 临床超声医学杂志, 2020, 22(10): 789-792.
[12] 成珍珍, 刘勇. 三维斑点追踪成像定量评价2型糖尿病患者左室收缩功能[J]. 临床超声医学杂志, 2020, 22(6): 411-414.
[13] 陈峥, 桂书彦, 李加平, 等. 三维超声联合斑点追踪对2型糖尿病患者心脏功能早期损伤应用分析[J]. 医学影像学杂志, 2022, 32(5): 865-868.
[14] 黎涛. 糖化血红蛋白、同型半胱氨酸、纤维蛋白原与2型糖尿病患者微血管病变的相关性[J]. 海南医学, 2012, 23(24): 91-93.
[15] 国蓉, 李肖珏, 陈燕燕. 糖化血红蛋白在糖尿病筛查和诊断中的意义[J]. 海军军医大学学报, 2023, 44(4): 480-485.
[16] Lee, J. and Cho, J.H. (2021) Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diag-nosed Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal, 45, 337-338. [Google Scholar] [CrossRef] [PubMed]
[17] Zhao, H., Zhang, L.D., Liu, L.F., et al. (2021) Blood Levels of Gly-cated Hemoglobin, D-Dimer, and Fibrinogen in Diabetic Retinopathy. Diabetes, Metabolic Syndrome and Obesity, 14, 2483-2488. [Google Scholar] [CrossRef
[18] 刘芳, 石晶, 张军, 等. 应用三维斑点追踪技术评价2型糖尿病患者左心室收缩功能[J]. 中国医学影像技术, 2013, 29(5): 752-756.
[19] 汤春梦, 李文和, 杨超超, 等. 血红蛋白糖化指数与2型糖尿病患者视网膜病变的相关性研究[J]. 中国糖尿病杂志, 2021, 29(5): 349-352.
[20] 唐明照, 吴吕燕. Cys-C、HCY、Hs-CRP、β2-MG、Cr联合检测对糖尿病肾病诊断的应用价值[J]. 海南医学, 2012, 23(3): 86-87.
[21] Kim, K.J., Choi, J., Bae, J.H., et al. (2021) Time to Reach Target Glycosylated Hemoglobin Is Associated with Long- Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study. Diabetes & Metabolism Journal, 45. 368-378. [Google Scholar] [CrossRef] [PubMed]
[22] 谢娟娟, 刘明辉, 赵白桦, 等. 实时三平面组织多普勒成像技术评价糖尿病患者左心室功能及与HbA1c的关系[J]. 中国医学影像技术, 2010, 26(9): 1695-1699.
[23] 邱顺平, 李志荣, 王亚, 等. 三维斑点追踪技术评估2型糖尿病早期左室心肌应变及与糖化血红蛋白的相关性研究[J]. 中国当代医药, 2019, 26(28): 173-175, 179.
[24] 吴凌恒, 陈建雄, 张梦娇, 等. 血糖控制不理想对2型糖尿病患者亚临床心肌收缩功能的影响研究[J]. 上海交通大学学报(医学版), 2023, 43(8): 1024-1031.
[25] Selvin, E., Lazo, M., Chen, Y., et al. (2014) Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage. Circulation, 130, 1374-1382. [Google Scholar] [CrossRef
[26] Ortiz-Martínez, M., Gonzá-lez-González, M., Martagón, A.J., et al. (2022) Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus. Current Diabetes Reports, 22, 95-115. [Google Scholar] [CrossRef] [PubMed]
[27] El Hayek, M.S., Ernande, L., Benitah, J.P., et al. (2021) The Role of Hyperglycaemia in the Development of Diabetic Cardiomyopathy. Archives of Cardiovascular Diseases, 114, 748-760. [Google Scholar] [CrossRef] [PubMed]
[28] Guido, M.C., Marques, A.F., Tavares, E.R., et al. (2017) The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 5343972. [Google Scholar] [CrossRef] [PubMed]
[29] 应康, 郭良云, 刘燕娜, 等. 基于三维斑点追踪成像评估左心室心肌应变对2型糖尿病患者发生主要不良心脏事件的预测[J]. 中国超声医学杂志, 2023, 39(8): 883-886.
[30] Avagimyan, A., Popov, S. and Shalnova, S. (2022) The Pathophysiological Basis of Diabetic Cardiomy-opathy Development. Current Problems in Cardiology, 47, Article ID: 101156. [Google Scholar] [CrossRef] [PubMed]
[31] Frustaci, A., Kajstura, J., Chimenti, C., et al. (2000) Myocar-dial Cell Death in Human Diabetes. Circulation Research, 87, 1123-1132. [Google Scholar] [CrossRef
[32] Seferović, P.M. and Polovina, M. (2020) In Search of a “Safety Zone” for Glycaemic Control: Association between Glycosylated Haemoglobin Levels and Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease. European Journal of Heart Failure, 22, 2035-2037. [Google Scholar] [CrossRef] [PubMed]